ARPA-H To Spend $160M On Gene Editing Drug Development

ARPA-H To Spend $160M On Gene Editing Drug Development The U.S.’ “moonshot” agency for health research will support seven teams across the country pursuing custom gene editing treatments for a spate of rare diseases that affect different organ systems, Stat reports. Also in the news: the Trump administration’s proposed overhaul of federal grantmaking; a look ahead toward the midterm elections; and more. https://kffhealthnews.org/morning-breakout/administration-news-071026/